Synthesis of the AChE inhibitor [phenyl-7-3H] (−)-phenserine tartrate at high specific activity
暂无分享,去创建一个
[1] N. Greig,et al. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. , 2005, Current Alzheimer research.
[2] C. N. Filer,et al. Tritium labelling and characterization of the cognition enhancing drug tacrine using several precursors. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[3] N. Greig,et al. Clinical pharmacokinetics of physostigmine in patients with Alzheimer's disease , 1995, Clinical pharmacology and therapeutics.
[4] N. Greig,et al. Total Synthesis of Racemic and Optically Active Compounds Related to Physostigmine and Ring‐C Heteroanalogues from 3‐[2′‐(dimethylamino)ethyl]2,3‐dihydro‐5‐methoxy‐1,3‐dimethyl‐1H‐indo l‐2‐ol , 1994 .
[5] A. Tizot,et al. Synthesis of [3H]zolpidem , 1986 .
[6] S. Murao,et al. Physostigmine and N8-Norphysostigmine, Insecticidal Compounds, from Streptomyces sp. , 1986 .
[7] A. Nieminen,et al. Interpretation of the 13C NMR spectrum of physostigmine , 1983 .
[8] L. Sorbera,et al. Phenserine tartrate: Treatment of Alzheimer's disease , 2003 .
[9] A. Brossi,et al. Phenserine, a Novel Anticholinesterase Related to Physostigmine: Total Synthesis and Biological Properties , 1996 .